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Abstract. Metastases of Merkel cell carcinoma in terms of diagnosing carcinomas with unknown primary 
localization. Poslavska О.V. Merkel cell carcinoma (MCC) is a rare malignant primary skin neoplasia with epithelial 
and neuroectodermal differentiation. The problem of MCC, which determines the relevance of its research, is often a 
high frequency of local recurrence, regional lymph node metastasis and further hematogenous and / or distant 
lymphogenous dissemination. Materials and methods. A retrospective analysis of the biopsy material of 6 patients with 
isolated MCC metastasis aged from 29 to 82 years (mean 63.11±16.24; median 62.5) was performed. For the control 
group, 9 cases of postoperative material of primary skin tumors with MCC of patients aged from 27 to 76 years 
(average 52.17±12.72; median 53.5) were selected to determine the differential diagnostic criteria. The results of the 
study. Carcinomas without primary localization can be interpreted as metastases from MCC, if they demonstrate the 
phenotype Cytokeratin, Ran AE1 / AE3 (paranuclear +) / CK20 (paranuclear +) / Vimentin (-) / CD45 (-) / S100 (-) / 
Chromogranin A ( +) / Synaptophysin (+), as well as possess nuclei, the area and perimeter of which are 2 times higher 
than that of normal lymphocytes (all p>0.05). Conclusions. Metastatic MCC without primary localization, in com-
parison with locally spreading, often demonstrate low-differentiated small-cell and transitional forms, which require 
additional immunohistochemical studies to exclude metastases of carcinoma of other origin. 
 
Реферат. Метастазы карциномы из клеток Меркеля с точки зрения диагностики опухолей неизвестной 
первичной локализации. Пославская А.В. Карцинома из клеток Меркеля (ККМ) – редкая злокачественная 
первичная неоплазия кожи с эпителиальной и нейроэктодермальной дифференцировкой. Проблемой ККМ, 
которая обуславливает актуальность её исследования, часто является высокая частота локального рецидива, 
регионального метастазирования в лимфатические узлы и дальнейшая гематогенная и/или дистанционная 
лимфогенная диссеминация. Материалы и методы. В работе проведен ретроспективный анализ биопсийного 
материала 6 пациентов с изолированным метастазом ККМ возрастом от 29 до 82 лет  (среднее 63,11±16,24; 
медиана 62,5). Для контрольной группы были отобраны 9 случаев послеоперационного материала первичных 
опухолей кожи с ККМ пациентов возрастом от 27 до 76 лет (среднее 52,17±12,72; медиана 53,5) с целью 
определения дифференциально-диагностических критериев. Результаты исследования. Карциномы без пер-
вичной локализации могут быть интерпретированы как метастазы ККМ, если они демонстрируют фенотип 
Сytokeratin, Рan АЕ1/АЕ3 (парануклеарно +) / СК20 (парануклеарно +) / Vimentin (-) / CD45 (-) / S100 (-) / Chro-
mogranin A (+) / Synaptophysin (+), а также обладают ядрами, площадь  и периметр которых превышают в 2 
раза показатели обычных лимфоцитов (все p>0,05). Выводы. Метастатические ККМ без первичной 
локализации, в сравнении с местнораспространяющимися, чаще демонстрируют низкодифференцированные 
мелкоклеточные и переходные формы, которые требуют дополнительного проведения иммуногистохими-
ческого исследования с целью исключения метастазов карцином другого происхождения. 
 
Merkel cell carcinoma (MCC) is a rare malignant 
skin neoplasm with epithelial and neuroectodermal 
differentiation. Tumor cells of MCC share 
morphologic, immunochistochemical and ultrastruc-
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ture peculiarities with differentiated Merlel cells. 
But a direct histogenetic association is not proved 
and some researches consider them to be neoplasms 
from pluripotent progenitor cells.  They belong to 
the soft tissue neoplasias of the skin. For the first 
time they were described by Cyril Toker as 
trabecular carcinoma in 1972. Other synonyms 
include neuroendocrine skin carcinoma, primary 
small-cell carcinoma of the skin and skin 
APUDome. MCC-associated poliomavirus is con-
sidered to be the cause of development. 
According to WHO data for 2017 about 1.500 of 
new types of MCCs were registered in the United 
States, this is about 460 times as much as in 2011 
(more than 3 times for 6 years). More often it occurs 
in men than in women, i.e. 2:1. MCC is very ag-
gressive, more than 1/3 of the patients with this 
diagnosis die, this is 2 times exceeds the number of 
deaths from melanomas. It should be noted that up 
to 37% of cases are nodular form, and 6-12% 
present distant metastases. These tumors typically 
develop on the skin areas of the elderly (median age 
69 years) open to the sun exposure. Anatomical and 
geographic distribution of carcinoma from Merkel 
cells depends on solar radiation as the main factor. A 
relatively high prevalence of these neoplasms is in in 
patients with chronical immunosuppression [5, 7]. 
The head is involved in 50% of cases and the 
limbs – in 40%. The trunk and genitalia are involved 
in less than 10% of cases, involvement of the 
mucosa also were described. The majority of neo-
plasms present solid painless enlarged nodes or 
thickened plaques of a red, violet or body color, 
sometimes with ulcer. The majority of MCC is less 
than 2 cm in diameter, this sometimes complicates 
revealing the source in dissemination of the process. 
The complexity of diagnostics causes the need for 
immunohistochemical research, and the diagnostic 
search includes basal cell carcinoma, melanoma, 
lymphoma, ecrine carcinoma, low-differentiated 
squamous cell carcinoma, metastatic neuroblastoma, 
primary primitive neuroectodermal tumor and meta-
stases of neuroendocrine carcinoma [6, 8]. 
The problem of MCC which determines the 
relevance of its study is the high frequency of local 
relapse, regional metastasis to the lymph nodes and 
subsequent hematogenous and/or distant lympha-
denic proliferation. MCC metastases without a 
detected primary focus belong to 20% of favorable 
phenotypes with better prognosis, compared with 
other 80% of cancer phenotypes without primary 
localization [3]. But clinical diagnosis after such a 
histological diagnosis necessarily involves a complete 
examination, excluding other possible primary loca-
lizations and the presence of multiple metastases. 
The aim is to investigate the complex of morpho-
logical, morphometric and immunohistochemical 
characteristics of cases of isolated carcinoid meta-
stases from Merkel cells, in comparison with 
primary tumors of the skin of this origin, for the 
improvement of diagnostic algorithms. 
MATERIALS AND METHODS OF RESEARCH 
In this work a retrospective analysis of the 
histological, morphometric and immunohistological 
characteristics of the biopsy material was performed 
on 6 patients (4 men and 2 women) with isolated 
metastatic carcinoma from Merkel cells aged 29 to 
82 years (mean 63.11±16.24, median 62.5) on the 
basis of the morphological department of the medi-
cal and diagnostic center JSC “Pharmacies of 
Medical Academy” (Dnipro) for the period from 
2015 to 2017. For the control group for the compa-
rison of histological and morphometric characte-
ristics, 9 cases of postoperative material of primary 
skin tumors from Merkel cells carcinoma (5 woman 
and 4 men) aged 27 to 76 years (mean 52.17±12.72; 
median 53.5). Localization of the primary material 
was distributed as follows: 4 areas of cheeks, 3 - in 
the hip area, 1 - the skin of the leg and 1 - forearm. 
For the morphometric method, the Zeiss Primo 
Star - Axiocam ERC 5s microscope camera with the 
licensed ZEN 2 blue edition software was used, 
informative fields of view were recorded in .jpg 
format and processed in the ImageJ program with 
the definition of the perimeter, area and roundness of 
the nuclei (Fig. 1) according to the method described 
in other publications [1, 2]. The immunohistochemistry 
study was conducted according to the protocols of 
TermoScientific (TS), (USA). In sections with a 
thickness of more than 4 μm, the Lab Vision Quanto 
(TS, USA) visualization system was used to detect the 
protein chain using DAB Quanto Chromogen (TS, 
USA). Characteristics of monoclonal antibodies are 
listed in Table 1. 
Statistical analysis of the parameters of areas, 
perimeters and circle coefficient of cells was carried 
out in the programs ImageJ and Microsoft Excel 
with the calculation of minimum, maximum, 
median, arithmetic mean and standard deviation. 
RESULTS AND DISCUSSION 
The primary carcinomas from Merkel cells were 
represented by fine-cell "blue-cell" neoplasms 
consisting of the same cells with a round or oval 
nucleus and a poor cytoplasm. Clear nuclear 
membrane separates disperse chromatin and 
nucleoli. The attention was drawn to numerous 
mitotic figures and nucleic fragments (pycnosis, 
rexis), as well as individual differentiated elongated 
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cells were present. The tumors were located in the 
center of the dermis and in 4 out of 9 cases (44.44%) 
spread into subcutaneous tissue. Only in 1 of the 
cases epidermis was involved (pagetoid type of 
lesion), but in other observations there was 
ulceration of epidermis. 
 
T a b l e  1  
Primary monoclonal antibodies 
Primary antibodies Clon (dilution) Reaction localization 
Сytokeratin, Рan АЕ1/АЕ3(1:50) Cytoplasma 
Vimentin Ab-2/sp20 (1:200) Cytoplasma 
Chromogranin A sp12 (1:400) Cytoplasma 




Сytokeratin 7 (СК7) RCK105 (1:100) Cytoplasms 
Сytokeratin 20 (СК20) Ks 20.8 (1:100) Cytoplasma 
 
In most observations, the neoplasms formed 
diffuse nets and solid nests in the dermis. On the 
periphery there were trabecular patterns, in the form 
of "nets" and "garlands", in 2 out of 9 (22,22%) 
pseudorosettes  were formed. The dermis around 
tumor in 6 of 9 (66.67%) demonstrated a 
desmoplastic reaction and zonal tumor necroses with 
angiolymphatic involvement. According to the 
histological forms, primary MCCs were divided into 
three groups: trabecular MCC - 4 out of 9 (44,44%), 
transient - 3 out of 9 (33,33%), and small-cellular - 2 
out of 9 (22,22%). The indicators of the 




Fig. 1. Features of cell structure of primary Merkel cell carcinoma: study of morphometric parameters  
(area, perimeter and index of «roundness» of nuclei) by the ImageJ program: nuclei of angulated form,  
with clear nuclear membrane, which separates dispersion chromatin and nuclei.  
Arrow indicates nuclear fragments (pycnosis, rexis) 
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T a b l e  2  
Indicators of morphometric studies of metastases and primary carcinomas  
from Merkel cells in the ImageJ program 





Ratio of «roundness»   
(ImageJ parameter) 
ꭓ±SD 
Primary carcinoma from Merkel cells 37,263±5,689 23,067±1,523 0,795±0,045 
Metastasis of carcinomas from Merkel cells 34,862±5,933 22,454±2,093 0,802±0,064 
р p>0,05 p>0,05 p>0,05 
N o t e :  ꭓ±SD – mean ± standard deviation, statistically significant difference was considered in p<0.05. 
 
All carcinomas from Merkel cells have demon-
strated epithelial and neuroendocrine differentiation. 
Paranuclear punctated immunohistochemical stai-
ning of CK20 cytokeratins was specific, which in 
half of the observations had a cap-like perinuclear 
staining. Positive reaction was also found on the 
markers synaptophysin and chromogranin, CD117. 
And it was completely negative for the pan-
leukocytic antigen CD45, Vimentin, S100. 
All metastatic lesions were analyzed according to 
the patterns of the histological structure and cor-
responded to the epithelioid morphology and the 
phenotype of the Cytokeratin, Ran AE1 / AE3 (para-
nuclear +) / SK20 (paranuclear +) / Vimentin (-) / 
CD45 (-) / S100 (-) after the primary IgG antibody 
panels (Fig. 2) 
 
 
Fig. 2. Examples of metastatic lesions of lymph nodes with Merkel cell carcinoma without primary localization. 
A. G-E / paranuclear punctated immunohistochemical staining with Cytokeratin, Pan AE1 / AE3, ICH, 
additional staining with Mayer's hematoxylin (× 400). B. G -E/cap-like perinuclear staining CK20, IHC, 
additional staining with Mayer's hematoxylin (× 400). C. G-E / negative reaction of Vimentin in tumor cells and 
positive in lymphoid cells of the environment, IHC, additional staining with Meyer's hematoxylin (× 400).  
D. G-E / Intranuclear reaction with KI-67, proliferative activity up to 53%, IHC,  
additional coloring with Mayer's hematoxylin (× 400) 
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Morphological types of metastatic carcinoma 
from Merkel cells included 2 transitional forms and 
4 small-cell carcinomas, which were much less 
commonly exhibited trabecular patterns or pseu-
dorosettes, whereas they had solid fields of mono-
morphic cells with intravascular invasion and 
stromal response. The difference in the distribution 
of histological forms of primary and metastatic 
MCC was reflected in the decrease in the size of 
cells of metastatic MCC, but statistically significant 
differences between the study groups revealed by the 
indicators of their morphometric study with ImageJ 
program was not found (all p>0.05) (Table 2) . 
For the purpose of differential diagnosis of MCC 
with other carcinomas, morphometric indices of 
primary and metastatic carcinomas from Merkel 
cells were compared with Vimentin-positive lym-
phoid cells of the environment (Table 3). A twofold 
difference was found in the area and perimeter of 
MCC tumor cells of both groups and normal 
lymphocytes (p (1) <0.05, p (2) <0.05). 
 
T a b l e  3  
Indicators of morphometric studies of metastases and primary carcinomas  
of Merkel cells in the ImageJ program 





Ratio of «roundness»  
(ImageJ parameter) 
ꭓ±SD 
Primary carcinoma from Merkel cells (1) 37,263±5,689 23,067±1,523 0,795±0,045 
Metastasis of carcinomas from Merkel cells (2) 34,862±5,933 22,454±2,093 0,802±0,064 








N o t e :  ꭓ±SD – mean ± standard deviation, statistically significant difference was considered in p<0.05. 
 
By the data of previous studies, MCC often has 
deletion on the short arm of chromosome 1 (lp36) 
and is common to other neuroendocrine tumors such 
as melanoma and neuroblastoma. Numerous other 
chromosomal lesions are described, for example, 
trisomy by 6 chromosome, approximately to 50% of 
tumors. Thus, some researchers believe that this 
tumor originates from primitive epidermal stem cells 
that can become epidermis or neuroendocrine cells. 
According to a combination of risk factors, 
progression of carcinomas from Merkel cells 
includes: more advanced age, localization on the 
head and neck, the size of more than 2 cm, 
immunosuppression, and progression of the disease. 
Histopathological and immunohistochemical risk 
factors show more than 10 mitotic figures with large 
enlargement, small-cell histological form, 
angiolymphatic invasion and CD45 immuno-
reactivity. 
CONCLUSIONS 
1. Carcinomas without primary localization can 
be interpreted as metastasis of carcinoma from 
Merkel cells if they exhibit the phenotype of 
Cytokeratin, Phen AE1 / AE3 (paranuclear +) / 
CK20 (paranuclear +) / Vimentin (-) / CD45 (-) / 
S100 (- ) / Chromogranin A (+) / Synaptophysin (+), 
and also have nuclei whoich area and perimeter 
exceeds 2 times the corresponding indices of normal 
lymphocytes (all p> 0.05). 
2. Metastatic carcinomas from Merkel cells, 
compared with primary ones, often show low-dif-
ferentiated small-cell and transitional forms 
requiring additional immunohistochemical studies to 
exclude metastases of carcinomas of other origin. 
The research was carried out within the fra-
mework of the research work of the Department of 
Pathological Anatomy and Forensic Medicine of the 
SE "Dnipropetrovsk Medical Academy of Health 
Ministry of Ukraine" "Development of diagnostic 
and prognostic criteria for neoplasms of different 
localizations, taking into account the biological 
parameters of the activity of the tumor process" 
(state registration number 0116U002827, execution 
period 2016-2018). 
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